SPRY |
ARS Pharmaceuticals, Inc. |
Aug 26, 2024 |
1 |
-$1.09M |
4 |
Aug 28, 2024 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Aug 21, 2024 |
4 |
-$11.5M |
4 |
Aug 23, 2024 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Jun 20, 2024 |
1 |
$0 |
4 |
Jun 24, 2024 |
Director |
CRVS |
Corvus Pharmaceuticals, Inc. |
Jun 13, 2024 |
1 |
$0 |
4 |
Jun 17, 2024 |
Director, 10%+ Owner |
EWTX |
Edgewise Therapeutics, Inc. |
Jun 10, 2024 |
1 |
$0 |
4 |
Jun 12, 2024 |
Director, 10%+ Owner |
ALPN |
ALPINE IMMUNE SCIENCES, INC. |
May 18, 2024 |
9 |
$0 |
4 |
May 20, 2024 |
Director |
CRVS |
Corvus Pharmaceuticals, Inc. |
May 6, 2024 |
2 |
$2.5M |
4 |
May 8, 2024 |
Director, 10%+ Owner |
EWTX |
Edgewise Therapeutics, Inc. |
Jan 23, 2024 |
1 |
$5M |
4 |
Jan 25, 2024 |
Director, 10%+ Owner |
ALPN |
ALPINE IMMUNE SCIENCES, INC. |
Jan 11, 2024 |
2 |
$1.85M |
4 |
Jan 16, 2024 |
Director |
ALPN |
ALPINE IMMUNE SCIENCES, INC. |
Jan 2, 2024 |
1 |
$0 |
4 |
Jan 4, 2024 |
Director |
ALPN |
ALPINE IMMUNE SCIENCES, INC. |
Dec 27, 2023 |
6 |
-$28.7M |
4 |
Dec 29, 2023 |
Director |
CRVS |
Corvus Pharmaceuticals, Inc. |
Dec 6, 2023 |
1 |
$0 |
4 |
Dec 8, 2023 |
Director, 10%+ Owner |
SPRY |
ARS Pharmaceuticals, Inc. |
Aug 29, 2023 |
1 |
$3.1M |
4 |
Aug 31, 2023 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Jun 27, 2023 |
1 |
$0 |
4 |
Jun 28, 2023 |
Director, 10%+ Owner |
CRVS |
Corvus Pharmaceuticals, Inc. |
Jun 15, 2023 |
1 |
$0 |
4 |
Jun 20, 2023 |
Director, 10%+ Owner |
EWTX |
Edgewise Therapeutics, Inc. |
Jun 12, 2023 |
1 |
$0 |
4 |
Jun 14, 2023 |
Director, 10%+ Owner |
ALPN |
ALPINE IMMUNE SCIENCES, INC. |
Jan 3, 2023 |
1 |
$0 |
4 |
Jan 5, 2023 |
Director |
EWTX |
Edgewise Therapeutics, Inc. |
Sep 16, 2022 |
1 |
$5M |
4 |
Sep 16, 2022 |
Director, 10%+ Owner |
CRVS |
Corvus Pharmaceuticals, Inc. |
Aug 11, 2022 |
1 |
$0 |
4 |
Aug 15, 2022 |
Director, 10%+ Owner |
EWTX |
Edgewise Therapeutics, Inc. |
Jun 24, 2022 |
1 |
$0 |
4 |
Jun 28, 2022 |
Director, 10%+ Owner |
DBTX |
Decibel Therapeutics, Inc. |
Jun 17, 2022 |
1 |
$0 |
4 |
Jun 21, 2022 |
Director, 10%+ Owner |
CRVS |
Corvus Pharmaceuticals, Inc. |
Jun 15, 2022 |
1 |
$0 |
4 |
Jun 17, 2022 |
Director, 10%+ Owner |
JANX |
Janux Therapeutics, Inc. |
Jun 14, 2022 |
1 |
$0 |
4 |
Jun 16, 2022 |
Director |
SPRY |
Silverback Therapeutics, Inc. |
Jun 10, 2022 |
1 |
$0 |
4 |
Jun 13, 2022 |
Director, 10%+ Owner |
EWTX |
Edgewise Therapeutics, Inc. |
May 18, 2022 |
1 |
$995K |
4 |
May 20, 2022 |
Director, 10%+ Owner |
ALPN |
ALPINE IMMUNE SCIENCES, INC. |
Jan 3, 2022 |
1 |
$0 |
4 |
Jan 4, 2022 |
Director, 10%+ Owner |
JANX |
Janux Therapeutics, Inc. |
Dec 29, 2021 |
2 |
-$820K |
4 |
Dec 30, 2021 |
Director |
JANX |
Janux Therapeutics, Inc. |
Dec 21, 2021 |
2 |
-$2.27M |
4 |
Dec 23, 2021 |
Director |
JANX |
Janux Therapeutics, Inc. |
Dec 16, 2021 |
2 |
-$7.5M |
4 |
Dec 17, 2021 |
Director |
CRVS |
Corvus Pharmaceuticals, Inc. |
Sep 20, 2021 |
1 |
-$6.76M |
4 |
Sep 22, 2021 |
Director, 10%+ Owner |
ALPN |
ALPINE IMMUNE SCIENCES, INC. |
Sep 17, 2021 |
2 |
$9.5M |
4 |
Sep 21, 2021 |
Director, 10%+ Owner |
CRVS |
Corvus Pharmaceuticals, Inc. |
Sep 9, 2021 |
1 |
$0 |
4 |
Sep 13, 2021 |
Director, 10%+ Owner |
JANX |
Janux Therapeutics, Inc. |
Jun 15, 2021 |
8 |
$12M |
4 |
Jun 16, 2021 |
Director |
CRVS |
Corvus Pharmaceuticals, Inc. |
Jun 15, 2021 |
1 |
$0 |
4 |
Jun 16, 2021 |
Director, 10%+ Owner |
JANX |
Janux Therapeutics, Inc. |
Jun 10, 2021 |
1 |
$0 |
4 |
Jun 14, 2021 |
Director, 10%+ Owner |
JANX |
Janux Therapeutics, Inc. |
Jun 10, 2021 |
0 |
$0 |
3 |
Jun 10, 2021 |
Director |
SPRY |
Silverback Therapeutics, Inc. |
Jun 4, 2021 |
1 |
$0 |
4 |
Sep 21, 2021 |
Director, 10%+ Owner |
PMVP |
PMV Pharmaceuticals, Inc. |
Jun 2, 2021 |
1 |
$0 |
4 |
Jun 9, 2021 |
Director, 10%+ Owner |